S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
NASDAQ:SURG

SurgePays - SURG Stock Forecast, Price & News

$5.95
-0.25 (-4.03%)
(As of 02/7/2023 12:00 AM ET)
Add
Compare
Today's Range
$5.78
$6.25
50-Day Range
$5.76
$7.50
52-Week Range
$2.51
$7.61
Volume
117,825 shs
Average Volume
90,969 shs
Market Capitalization
$82.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.88

SurgePays MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
99.6% Upside
$11.88 Price Target
Short Interest
Bearish
17.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars

Computer And Technology Sector

496th out of 610 stocks

Advertising Industry

8th out of 10 stocks

SURG stock logo

About SurgePays (NASDAQ:SURG) Stock

SurgePays, Inc. operates as a technology-driven company, which focuses on building a supply chain software platform as an alternative to traditional wholesale supply chain distribution models. It offers goods and services direct to convenience stores, bodegas, minimarts, tiendas and other corner stores, providing goods and services primarily to the underbanked community. The company was founded on August 18, 2006 and is headquartered in Bartlett, TN.

Receive SURG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SurgePays and its competitors with MarketBeat's FREE daily newsletter.

SURG Stock News Headlines

A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
SurgePays Provides Shareholder Update
SurgePays Announces Changes To Its Board Of Directors
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
SurgePays Announces Third Quarter 2022 Financial Results
Jeremy Gies Appointed President of SurgePays Fintech
GPOPlus+ Signs Master Services Agreement with SurgePays
SurgePays Passes 200,000 Mobile Broadband Subscribers
See More Headlines
Receive SURG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SurgePays and its competitors with MarketBeat's FREE daily newsletter.

SURG Company Calendar

Last Earnings
11/14/2022
Today
2/07/2023
Next Earnings (Estimated)
3/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Advertising
Sub-Industry
N/A
Current Symbol
NASDAQ:SURG
Fax
N/A
Employees
32
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.88
High Stock Price Forecast
$15.00
Low Stock Price Forecast
$8.75
Forecasted Upside/Downside
+99.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-13,530,000.00
Pretax Margin
-10.79%

Debt

Sales & Book Value

Annual Sales
$51.06 million
Book Value
$0.29 per share

Miscellaneous

Free Float
8,409,000
Market Cap
$82.29 million
Optionable
Not Optionable
Beta
1.20

Key Executives

  • Kevin Brian Cox
    Chairman & Chief Executive Officer
  • Anthony G. Evers
    Chief Financial Officer
  • John MottJohn Mott
    Chief Technology Officer
  • David C. Ansani
    Secretary, Chief Administrative Officer
  • Carter Matzinger
    Chief Strategic Officer













SURG Stock - Frequently Asked Questions

Should I buy or sell SurgePays stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SurgePays in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SURG shares.
View SURG analyst ratings
or view top-rated stocks.

What is SurgePays' stock price forecast for 2023?

1 Wall Street research analysts have issued 1 year price objectives for SurgePays' stock. Their SURG share price forecasts range from $8.75 to $15.00. On average, they expect the company's share price to reach $11.88 in the next twelve months. This suggests a possible upside of 91.5% from the stock's current price.
View analysts price targets for SURG
or view top-rated stocks among Wall Street analysts.

How have SURG shares performed in 2023?

SurgePays' stock was trading at $6.56 at the beginning of 2023. Since then, SURG shares have decreased by 5.5% and is now trading at $6.20.
View the best growth stocks for 2023 here
.

When is SurgePays' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023.
View our SURG earnings forecast
.

How were SurgePays' earnings last quarter?

SurgePays, Inc. (NASDAQ:SURG) announced its earnings results on Monday, November, 14th. The medical equipment provider reported ($0.12) EPS for the quarter. The medical equipment provider earned $36.17 million during the quarter. SurgePays had a negative net margin of 10.58% and a negative trailing twelve-month return on equity of 492.78%.

What other stocks do shareholders of SurgePays own?
What is SurgePays' stock symbol?

SurgePays trades on the NASDAQ under the ticker symbol "SURG."

Who are SurgePays' major shareholders?

SurgePays' stock is owned by a number of institutional and retail investors. Top institutional investors include Equitec Proprietary Markets LLC (0.00%), FNY Investment Advisers LLC (0.07%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David Allen May, John Mott and Kevin Brian Cox.
View institutional ownership trends
.

How do I buy shares of SurgePays?

Shares of SURG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SurgePays' stock price today?

One share of SURG stock can currently be purchased for approximately $6.20.

How much money does SurgePays make?

SurgePays (NASDAQ:SURG) has a market capitalization of $85.75 million and generates $51.06 million in revenue each year. The medical equipment provider earns $-13,530,000.00 in net income (profit) each year or ($1.17) on an earnings per share basis.

How can I contact SurgePays?

SurgePays' mailing address is 3845 Corporate Centre Dr, O'FALLON, MO 63368-8678, United States. The official website for the company is www.surgeholdings.com. The medical equipment provider can be reached via phone at (901) 302-9587 or via email at invest@surgepays.com.

This page (NASDAQ:SURG) was last updated on 2/7/2023 by MarketBeat.com Staff